We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+1.22%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$57.1B
AUM Growth
-$109M
Cap. Flow
-$507M
Cap. Flow %
-0.89%
Top 10 Hldgs %
13.27%
Holding
3,274
New
730
Increased
855
Reduced
816
Closed
774

Sector Composition

Rank Sector Weight
1 Industrials 9.54%
2 Consumer Discretionary 9.3%
3 Financials 8.79%
4 Technology 8.62%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUIK icon
2976
QuickLogic
QUIK
$210M
-16,182
Closed -$259K
RARE icon
2977
Ultragenyx Pharmaceutical
RARE
$2.55B
-28,743
Closed -$1.34M
RAPT
2978
DELISTED
RAPT Therapeutics
RAPT
-7,244
Closed -$520K
RCL icon
2979
PUT
Royal Caribbean
RCL
$78.1B
-4,100
Closed -$570K
RDN icon
2980
Radian Group
RDN
$4.84B
-30,950
Closed -$1.04M
RDY icon
2981
Dr. Reddy's Laboratories
RDY
$10.1B
-76,890
Closed -$1.13M
REKR icon
2982
Rekor Systems
REKR
$83.6M
-88,331
Closed -$202K
LNAI
2983
Lunai Bioworks
LNAI
$9.75M
-492
Closed -$104K
REX icon
2984
REX American Resources
REX
$1.47B
-17,068
Closed -$501K
RGEN icon
2985
Repligen
RGEN
$10.2B
-77,176
Closed -$14.2M
RGLS
2986
DELISTED
Regulus Therapeutics
RGLS
-24,253
Closed -$69.8K
RGTI icon
2987
Rigetti Computing
RGTI
$5.98B
-104,229
Closed -$159K
RIG icon
2988
Transocean
RIG
$6.61B
-3,297,560
Closed -$19.1M
RIO icon
2989
Rio Tinto
RIO
$171B
-13,220
Closed -$843K
RIO icon
2990
PUT
Rio Tinto
RIO
$171B
-16,900
Closed -$1.08M
RKT icon
2991
PUT
Rocket Companies
RKT
$39.4B
-400,000
Closed -$5.82M
RLMD icon
2992
Relmada Therapeutics
RLMD
$494M
-12,322
Closed -$57.3K
RDNW
2993
RideNow Group
RDNW
$233M
-42,743
Closed -$276K
RMD icon
2994
CALL
ResMed
RMD
$33.4B
-2,200
Closed -$436K
RNAM
2995
DELISTED
Avidity Biosciences
RNAM
-51,055
Closed -$1.3M
RNW icon
2996
ReNew
RNW
$2.48B
-63,238
Closed -$379K
ROK icon
2997
PUT
Rockwell Automation
ROK
$48.5B
-1,100
Closed -$320K
ROST icon
2998
PUT
Ross Stores
ROST
$76.7B
-21,200
Closed -$3.11M
RPM icon
2999
RPM International
RPM
$13.9B
-5,903
Closed -$702K
RS icon
3000
Reliance Steel & Aluminium
RS
$19.8B
-200,188
Closed -$66.9M

Similar funds

Dmitry Balyasny's Q2 2024 Portfolio in Review

As of Q2 2024, Dmitry Balyasny held 3,274 positions worth $57.1B, down 0.19% from $57.2B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Dmitry Balyasny's Q2 2024 filing shows 730 new, 855 increased, 816 reduced and 774 closed positions. Its largest new stake was Intercontinental Exchange: 1,498,857 shares worth $205M. The largest sale was Pioneer Natural Resource Co., an estimated $777M.

By sector, the portfolio is most concentrated in Industrials at 9.5% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Dmitry Balyasny's largest Q2 2024 buy was Intercontinental Exchange: 1,498,857 shares worth $205M.
  • Dmitry Balyasny added most to Apple in Q2 2024, an estimated $444M increase.
  • Dmitry Balyasny's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $317M.
  • Dmitry Balyasny fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $777M.
  • Dmitry Balyasny's ten largest holdings make up 13% of its $57.1B portfolio in Q2 2024.
  • Dmitry Balyasny opened 730 new positions and closed 774 in Q2 2024.
  • Dmitry Balyasny's portfolio value fell 0.19% quarter-over-quarter to $57.1B.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.